Liver mTOR controls IGF-I bioavailability by regulation of protein kinase CK2 and IGFBP-1 phosphorylation in fetal growth restriction

Medicine and Dentistry

• Fetus Growth 100%
• Phosphorylation 60%
• Mechanistic Target of Rapamycin 60%
• Liver 50%
• Western Blot 40%
• Hyperphosphorylation 30%
• Growth 30%
• Fetus 30%
• Hepatocyte 20%
• Enzyme Linked Immunosorbent Assay 20%
• Bioavailability 20%
• Cells 20%
• Regulatory Mechanism 20%
• Nutrient 20%
• Receptor 10%
• Antibody 10%
• Diabetes 10%
• Cardiovascular Disease 10%
• Pathophysiology 10%
• Cord Blood 10%
• Enzymatic Assay 10%
• Gestational Age 10%
• Life 10%
• Newborn Disease 10%
• Autophosphorylation 10%
• Casein Kinase II 10%
• Therapeutic Procedure 10%
• Human 10%
• Plasma 10%
• Infant 10%

Biochemistry, Genetics and Molecular Biology

• Fetus Growth 100%
• Phosphorylation 60%
• Baboon 60%
• Mammalian Target of Rapamycin 60%
• Hyperphosphorylation 30%
• Growth 30%
• Hepatocyte 20%
• Regulatory Mechanism 20%
• Protein Kinase 10%
• Human 10%
• Autophosphorylation 10%
• Age 10%
• Life 10%
• Antibody 10%